GCT Semiconductor Holding, Inc.

NYSE: GCTS

GCT Semiconductor Holding, Inc.
Private Placement up to $20M

ARC Group acted as Co-Investor to GCT Semiconductor Holding, Inc.
December 2025

BioNexus Gene Lab Corp.

NASDAQ: BGLC

BioNexus Gene Lab Corp.
Private Placement up to $500M

ARC Group acted as Investor to BioNexus Gene Lab Corp.
November 2025

Miluna Acquisition Corp.

NASDAQ: MMTXU

Miluna Acquisition Corp.
Initial Public Offering $60M

ARC Group acted as Financial Advisor to Miluna Acquisition Corp
October 2025

ScanTech AI Systems Inc.

NASDAQ: STAI

ScanTech AI Systems Inc.
Private Placement up to $50M

ARC Group acted as Investor to ScanTech AI Systems Inc.
October 2025

Titan Pharmaceuticals, Inc. with TalenTec Sdn. Bhd.

NASDAQ: BTTC

Titan Pharmaceuticals, Inc. with TalenTec Sdn. Bhd.
Merger Undisclosed Amount

Sole Financial Advisor
October 2025

XRP Healthcare M&A Holding Inc. with AAJ Capital 3 Corp.

TSXV: AAAJ.P

XRP Healthcare M&A Holding Inc. with AAJ Capital 3 Corp.
RTO

Sole Financial Advisor to XRP Healthcare M&A Holding Inc.
July 2025

Sagtec Global

NASDAQ: SAGT

Sagtec Global
Private Placement up to $25M

Financial Advisor to Sagtec
July 2025

D. Boral ARC Acquisition I Corp.

NASDAQ: BCAR

D. Boral ARC Acquisition I Corp.
SPAC IPO $250M

SPAC Sponsor
July 2025

Regal Planet Limited

Regal Planet Limited
Financing $5M

Financial Advisor
May 2025

Spectrum Sleep

Spectrum Sleep
Debt Financing $1.5M

Financial Advisor to Spectrum Sleep
May 2025

Cyclacel Pharmaceuticals with fitters Sdn. Bhd.

NASDAQ: CYCC, CYCCP

Cyclacel Pharmaceuticals with fitters Sdn. Bhd.
Strategic Share Exchange Agreement

Financial Advisor to Cyclacel
April 2025

Technosteel Construction with Sayward Capital

TSXV: SAWC. P

Technosteel Construction with Sayward Capital
RTO

Sole Financial Advisor to Technosteel
April 2025

BeLive Holdings Limited

NASDAQ: BLIV

BeLive Holdings Limited
IPO $10M

Financial Advisor to BeLive
April 2025

Tivic Health Systems, Inc.

NASDAQ: TIVC

Tivic Health Systems, Inc.
Convertible Preferred Financing $8.4M

Financial Advisor
April 2025

Cyclacel Pharmaceuticals

NASDAQ: CYCC, CYCCP

Cyclacel Pharmaceuticals
Private Placement $1M

Financial Advisor to Cyclacel
March 2025

Cyclacel Pharmaceuticals

NASDAQ: CYCC, CYCCP

Cyclacel Pharmaceuticals
Share Purchase $6.3M

Sole Financial Advisor
February 2025

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission